AUTHOR ARCHIVES

Results 1-1 of 1

FDA Let Drugs Approved on Fraudulent Research Stay on the Market

April 16, 2013 FROM NEXTGOV arrow On the morning of May 3, 2010, three agents of the Food and Drug Administration descended upon the Houston office of Cetero Research, a firm that conducted research for drug companies worldwide. Lead agent Patrick Stone, now retired from the FDA, had visited the Houston lab many times over the ...